<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — August 2025]]></title><description><![CDATA[<p dir="auto">Lundbecks kursmål sænkes til 50 kr. fra 53 kr. af DNB Carnegie <a href="https://proinvestor.com/investornyt/1347926/lundbecks-kursmal-saenkes-til-50-kr-fra-53-kr-af-dnb-carnegie" rel="nofollow ugc">https://proinvestor.com/investornyt/1347926/lundbecks-kursmal-saenkes-til-50-kr-fra-53-kr-af-dnb-carnegie</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400901/pharma-august-2025</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:08:07 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400901.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 06 Aug 2025 13:46:46 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — August 2025 on Mon, 25 Aug 2025 08:54:10 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck snart klar med nye data for opkøbt epilepsimiddel <a href="https://proinvestor.com/investornyt/1354593/lundbeck-snart-klar-med-nye-data-for-opkobt-epilepsimiddel" rel="nofollow ugc">https://proinvestor.com/investornyt/1354593/lundbeck-snart-klar-med-nye-data-for-opkobt-epilepsimiddel</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038299</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038299</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 25 Aug 2025 08:54:10 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Mon, 25 Aug 2025 08:43:11 GMT]]></title><description><![CDATA[<p dir="auto">Danske Bank ser muligheder i sundhedssektoren: Hæver til "overvægt" <a href="https://proinvestor.com/investornyt/1354620/danske-bank-ser-muligheder-i-sundhedssektoren-haever-til-overvaegt" rel="nofollow ugc">https://proinvestor.com/investornyt/1354620/danske-bank-ser-muligheder-i-sundhedssektoren-haever-til-overvaegt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038300</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038300</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 25 Aug 2025 08:43:11 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 22 Aug 2025 10:54:01 GMT]]></title><description><![CDATA[<p dir="auto">Usikkerhed - især i forhold til de amerikanske toldsatser - har redet dansk life science som en mare. Men nu er der afklaring - og det har sat sig positivt på C25. Derudover ser Helge Larsen på regnskaber fra Bavarian Nordic, GN Store Nord og Ambu. Kort video: <a href="https://proinvestor.com/boards/127943" rel="nofollow ugc">https://proinvestor.com/boards/127943</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038295</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038295</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 22 Aug 2025 10:54:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 22 Aug 2025 03:21:37 GMT]]></title><description><![CDATA[<p dir="auto">Pharma: Får toldafklaring investorerne til at vende tilbage? <a href="https://proinvestor.com/boards/127933" rel="nofollow ugc">https://proinvestor.com/boards/127933</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038298</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038298</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 22 Aug 2025 03:21:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 21 Aug 2025 06:54:49 GMT]]></title><description><![CDATA[<p dir="auto">Danske Stenocare, som sælger medicinsk cannabisolie, har i dette kvartal nået en milepæl, nemlig break-even. Endda tidligere end forventet. Helge Larsen har Stenocares CEO Thomas Skovlund Schnegelsberg og CFO Peter Bugge Johansen i studiet i forbindelse med selskabets halvårsregnskab - hvor de også kommer ind på det tyske marked, deres patenterede produkt, Astrum, og forventninger til 2026 og 2027. <a href="https://proinvestor.com/boards/127924" rel="nofollow ugc">https://proinvestor.com/boards/127924</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038294</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038294</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 21 Aug 2025 06:54:49 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 21 Aug 2025 05:20:07 GMT]]></title><description><![CDATA[<p dir="auto">Stenocare for første gang i break even på EBITDA <a href="https://proinvestor.com/investornyt/1353510/stenocare-for-forste-gang-i-break-even-pa-ebitda" rel="nofollow ugc">https://proinvestor.com/investornyt/1353510/stenocare-for-forste-gang-i-break-even-pa-ebitda</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038293</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038293</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 21 Aug 2025 05:20:07 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 21 Aug 2025 03:57:54 GMT]]></title><description><![CDATA[<p dir="auto">ALK leverer omsætningsvækst på 12 % i Q2 <a href="https://proinvestor.com/investornyt/1353501/alk-leverer-omsaetningsvaekst-pa-12-i-q2" rel="nofollow ugc">https://proinvestor.com/investornyt/1353501/alk-leverer-omsaetningsvaekst-pa-12-i-q2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038301</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038301</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 21 Aug 2025 03:57:54 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 15 Aug 2025 05:30:44 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får hævet kursmål af ABG efter opjustering og regnskab <a href="https://proinvestor.com/investornyt/1351759/lundbeck-far-haevet-kursmal-af-abg-efter-opjustering-og-regnskab" rel="nofollow ugc">https://proinvestor.com/investornyt/1351759/lundbeck-far-haevet-kursmal-af-abg-efter-opjustering-og-regnskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038296</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038296</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 15 Aug 2025 05:30:44 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 15 Aug 2025 03:35:28 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk og co: Hvem skal finansiere lavere amerikanske medicinalpriser? <a href="https://proinvestor.com/boards/127828" rel="nofollow ugc">https://proinvestor.com/boards/127828</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038290</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038290</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 15 Aug 2025 03:35:28 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 15 Aug 2025 03:15:43 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck sænket til "hold" hos Morningstar efter kursridt <a href="https://proinvestor.com/investornyt/1351715/lundbeck-saenket-til-hold-hos-morningstar-efter-kursridt" rel="nofollow ugc">https://proinvestor.com/investornyt/1351715/lundbeck-saenket-til-hold-hos-morningstar-efter-kursridt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038287</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038287</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 15 Aug 2025 03:15:43 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 15 Aug 2025 03:12:26 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får lagt ekstra på kursmålet hos SEB <a href="https://proinvestor.com/investornyt/1351717/lundbeck-far-lagt-ekstra-pa-kursmalet-hos-seb" rel="nofollow ugc">https://proinvestor.com/investornyt/1351717/lundbeck-far-lagt-ekstra-pa-kursmalet-hos-seb</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038292</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038292</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 15 Aug 2025 03:12:26 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Fri, 15 Aug 2025 02:23:48 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038288</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038288</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 15 Aug 2025 02:23:48 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 14 Aug 2025 11:10:00 GMT]]></title><description><![CDATA[<p dir="auto">Det vælter ind med regnskaber. Ét regnskab, Helge Larsen har særlig opmærksomhed på, er det fra Ørsted. Han er mildest talt ikke imponeret over, at selskabet skal ud og hente 60 mia. kr. Derudover kigger han på Vestas, ALK-Abelló, Lundbeck og Zealand Pharma. Kort video: <a href="https://proinvestor.com/boards/127811" rel="nofollow ugc">https://proinvestor.com/boards/127811</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038297</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038297</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 14 Aug 2025 11:10:00 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 14 Aug 2025 02:54:22 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck løber fra konsensus og opjusterer for anden gang i 2025 efter flot andet kvartal <a href="https://proinvestor.com/investornyt/1351105/lundbeck-lober-fra-konsensus-og-opjusterer-for-anden-gang-i-2025-efter-flot-andet-kvartal" rel="nofollow ugc">https://proinvestor.com/investornyt/1351105/lundbeck-lober-fra-konsensus-og-opjusterer-for-anden-gang-i-2025-efter-flot-andet-kvartal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038286</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038286</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 14 Aug 2025 02:54:22 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Thu, 14 Aug 2025 02:08:16 GMT]]></title><description><![CDATA[<p dir="auto">China pharma firms turn to local reagent suppliers to cut costs and delivery times - <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/china-pharma-firms-turn-local-reagent-suppliers-cut-costs-delivery-times-2025-08-13/" rel="nofollow ugc">https://www.reuters.com/business/healthcare-pharmaceuticals/china-pharma-firms-turn-local-reagent-suppliers-cut-costs-delivery-times-2025-08-13/</a> Reuters</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038289</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038289</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Thu, 14 Aug 2025 02:08:16 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Wed, 13 Aug 2025 15:38:04 GMT]]></title><description><![CDATA[<p dir="auto">Teknisk: Europæisk health care begynder at vise styrketegn <a href="https://proinvestor.com/investornyt/1350864/teknisk-europaeisk-health-care-begynder-at-vise-styrketegn" rel="nofollow ugc">https://proinvestor.com/investornyt/1350864/teknisk-europaeisk-health-care-begynder-at-vise-styrketegn</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038291</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038291</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 13 Aug 2025 15:38:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Wed, 13 Aug 2025 15:31:54 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck opjusterer for 2025 efter et stærkt første halvår <a href="https://proinvestor.com/boards/127791" rel="nofollow ugc">https://proinvestor.com/boards/127791</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038285</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038285</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 13 Aug 2025 15:31:54 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — August 2025 on Tue, 12 Aug 2025 12:05:09 GMT]]></title><description><![CDATA[<p dir="auto">ALK opjusterer forventningerne <a href="https://proinvestor.com/boards/127764" rel="nofollow ugc">https://proinvestor.com/boards/127764</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038284</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038284</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 12 Aug 2025 12:05:09 GMT</pubDate></item></channel></rss>